FDA 483 - Abbott Laboratories - September 24, 2019

An FDA inspection of Abbott Nutrition in Sturgis, MI, from September 16-24, 2019, revealed a significant issue regarding quality control. The firm failed to adequately test representative samples of powdered infant formula at the final product stage to ensure required microbiological quality standards were met. This indicates a serious lapse in ensuring product safety before distribution.